LexDanaLexDanabeta
Inventor

Veronique Blanchard-Bregeon

Inventor
Paris, FR

Overview

4→
Patents
2002–2017
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
A01KAnimal husbandry11%
C07KPeptides11%
C12NMicroorganisms or enzymes11%
PatentTitleYear
9,789,102'H3 receptor antagonist for use in the treatment of alzheimer\'s disease'20178,343,493'Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs'20137,700,823'Transgenic animals exhibiting major disorders related to Alzheimer\'s disease'20106,387,936'Combinations of riluzole and levodopa for the treatment of Parkinson\'s disease'2002

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2002–2010Patents assigned to AVENTIS PHARMA SA (2)· patent assignee history
2002–2017Based in Paris, FR· patent location history
2013–2017Patents assigned to SANOFI SA (2)· patent assignee history
2013Patents assigned to BLANCHARD-BREGEON VERONIQUE (1)· patent assignee history
2013Patents assigned to BUEE LUC (1)· patent assignee history
2013Patents assigned to DELACOURTE ANDRE (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
AVENTIS PHARMA SA22002–2010
SANOFI SA22013–2017
BLANCHARD-BREGEON VERONIQUEself12013
BUEE LUC12013
DELACOURTE ANDRE12013
Locations
LocationPatentsSpan
Paris, FR42002–2017